MICHAEL BARRERA: Open Payments
NPI 1669833232 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,813 in 138 payments from 17 companies in 2025. Trend: 2023 $2,585 · 2024 $2,946 · 2025 $2,813
Food & beverage: $2,803Education: $10
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 24 | $440 |
| Janssen Biotech, Inc. | 21 | $404 |
| ABBVIE INC. | 23 | $351 |
| PFIZER INC. | 15 | $250 |
| GENZYME CORPORATION | 8 | $244 |
| Regeneron Healthcare Solutions, Inc. | 7 | $239 |
| UCB, Inc. | 10 | $210 |
| Arcutis Biotherapeutics, Inc. | 6 | $168 |
| Lilly USA, LLC | 4 | $100 |
| E.R. Squibb & Sons, L.L.C. | 5 | $96 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, Bimzelx, Zoryve, RINVOQ, CIBINQO, COSENTYX.
Industry payments across FL — which companies pay providers there.
